Examkin

Soru

Zorluk: ZorGynecologic Oncology

During a routine health maintenance visit, a 61-year-old G2P2 complains of a three-month history of progressive abdominal bloating, early satiety, and pelvic heaviness. Her last menstrual period was 10 years ago, and she has never used hormone replacement therapy. Vital signs are within normal limits. Abdominal examination reveals fullness in the lower quadrants. Bimanual pelvic examination identifies a palpable, firm, irregular, and fixed mass in the right adnexa. Arrange the following steps in the most appropriate chronological sequence for the diagnostic workup and therapeutic management of this patient.

  1. 1Performance of transvaginal ultrasonography to evaluate the mass
  2. 2Measurement of serum CA-125 concentration
  3. 3Calculation of a malignancy risk index combining clinical and diagnostic data
  4. 4Consultation and referral to a gynecologic oncology subspecialist
  5. 5Exploratory laparotomy for surgical staging and cytoreduction

Cevap

The correct sequence begins with transvaginal ultrasonography to characterize the physical properties of the mass, followed by measurement of serum CA-125. These diagnostic data points are then used to calculate a malignancy risk index, which directs the referral of the patient to a gynecologic oncologist. The specialist ultimately performs an exploratory laparotomy for staging and cytoreduction.
The established standard of care for a postmenopausal woman presenting with a suspicious pelvic mass dictates a sequential, structured approach. The workup must begin with transvaginal ultrasonography to establish the presence and morphological complexity of the mass. Once a complex mass is confirmed, serum CA-125 is measured. Because isolated clinical intuition is insufficient, these factors are objectively combined into a risk stratification model (such as the Risk of Malignancy Index). Patients identified as high-risk must then be referred to a gynecologic oncologist. Finally, the subspecialist performs the definitive intervention: an exploratory laparotomy for histological confirmation, staging, and tumor cytoreduction.

Adım Adım Çözüm

1
Characterize the adnexal mass morphologically
Transvaginal ultrasound is performed
This is the gold-standard initial modality to assess the physical properties of any newly palpated pelvic mass and identify features suspicious for malignancy.
2
Assess biochemical tumor markers
Serum CA-125 is measured
Provides vital serologic evidence to support the suspicion of epithelial ovarian malignancy in a postmenopausal patient presenting with a complex adnexal mass.
3
Synthesize data for objective risk stratification
A malignancy risk index is calculated
Combines morphological (ultrasound), serological (CA-125), and clinical (menopausal status) data into a standardized triage score.
4
Determine the appropriate level of surgical care
Patient is referred to a gynecologic oncologist
High-risk predictive scores mandate specialized surgical expertise to ensure the patient receives appropriate staging and maximal debulking.
5
Perform definitive diagnostic and therapeutic management
Exploratory laparotomy is conducted
Achieves both definitive histological diagnosis and therapeutic cytoreduction, which directly correlates with improved survival outcomes.

Anahtar Kavram

Sequential triage, risk stratification, and surgical management of a suspicious adnexal mass in a postmenopausal patient.
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru